Category Specific RSS

heart disease

EchoIQ develops AI to detect heart failure, lays out FDA pathway

In Australia, heart failure affects over half a million individuals, making up over 150,000 hospitalisations per year, over 60,000 deaths,…

1 year ago

Respiri and Echo IQ team up to expand into the US with heart disease detection and remote post-consultation care

AI and medical technology firm Echo IQ Limited (ASX: EIQ) has inked a commercial licensing agreement with respiratory health MedTech…

2 years ago

Artrya seeking to improve its chances of getting FDA approval for AI heart disease screener

“Coronary Artery Disease. We see you.” Quite literally, healthcare company Artrya (ASX: AYA) sees your heart disease through its artificial…

3 years ago

US-based heart centre to trial Artrya’s software for heart disease diagnosis

Coronary heart disease is the most prevalent type of heart disease and the leading single cause of death in Australia,…

3 years ago